MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
about
Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kB signaling pathways.Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.Emerging drugs for treating skeletal muscle injury and promoting muscle repair.Mechanisms of the beneficial effects of vitamin B6 and pyridoxal 5-phosphate on cardiac performance in ischemic heart disease.Pyridoxamine improves survival and limits cardiac dysfunction after MI.
P2860
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
@ast
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
@en
type
label
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
@ast
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
@en
prefLabel
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
@ast
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
@en
P2093
P2860
P1476
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
@en
P2093
Albert D Friesen
David E Kandzari
Deborah A Douglas
G Karl-Gunnar Hidinger
Jean-Pierre Dery
Marjorie E Zettler
P2860
P304
P356
10.1517/13543784.14.11.1435
P407
P577
2005-11-01T00:00:00Z